nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—portal vein—Crohn's disease	0.411	0.702	CbGeAlD
Ximelagatran—F2—gall bladder—Crohn's disease	0.0706	0.121	CbGeAlD
Ximelagatran—F2—epithelium—Crohn's disease	0.0365	0.0624	CbGeAlD
Ximelagatran—F2—Common Pathway—F5—Crohn's disease	0.0293	0.0706	CbGpPWpGaD
Ximelagatran—F2—lymphoid tissue—Crohn's disease	0.0281	0.0481	CbGeAlD
Ximelagatran—F2—digestive system—Crohn's disease	0.0278	0.0475	CbGeAlD
Ximelagatran—F2—Blood Clotting Cascade—F5—Crohn's disease	0.0249	0.0601	CbGpPWpGaD
Ximelagatran—F2—Formation of Fibrin Clot (Clotting Cascade)—F5—Crohn's disease	0.0168	0.0405	CbGpPWpGaD
Ximelagatran—F2—Complement and Coagulation Cascades—F5—Crohn's disease	0.0113	0.0273	CbGpPWpGaD
Ximelagatran—CYP2C9—digestive system—Crohn's disease	0.0111	0.0189	CbGeAlD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IL18—Crohn's disease	0.011	0.0265	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—GPX4—Crohn's disease	0.0102	0.0247	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—MPO—Crohn's disease	0.00958	0.0231	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—RASGRP1—Crohn's disease	0.00953	0.023	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—ICAM1—Crohn's disease	0.00846	0.0204	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00815	0.0197	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—GPX4—Crohn's disease	0.00812	0.0196	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—MLN—Crohn's disease	0.00783	0.0189	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—MPO—Crohn's disease	0.00779	0.0188	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00773	0.0187	CbGpPWpGaD
Ximelagatran—F2—Post-translational protein modification—SBSPON—Crohn's disease	0.00772	0.0186	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.007	0.0169	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IFNG—Crohn's disease	0.00644	0.0155	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—MPO—Crohn's disease	0.00619	0.0149	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IL1B—Crohn's disease	0.00574	0.0139	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00547	0.0132	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00536	0.0129	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00519	0.0125	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—GPR65—Crohn's disease	0.00505	0.0122	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—CRP—Crohn's disease	0.00504	0.0122	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ICAM1—Crohn's disease	0.00463	0.0112	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—ITGA4—Crohn's disease	0.0046	0.0111	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00451	0.0109	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—ALB—Crohn's disease	0.00434	0.0105	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—ACKR2—Crohn's disease	0.00417	0.0101	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00414	0.01	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—CRP—Crohn's disease	0.0041	0.00989	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—MLN—Crohn's disease	0.00395	0.00953	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.00393	0.00949	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—ALB—Crohn's disease	0.00386	0.00932	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ICAM1—Crohn's disease	0.00377	0.00909	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—SBSPON—Crohn's disease	0.00367	0.00884	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00359	0.00867	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00355	0.00856	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IFNG—Crohn's disease	0.00352	0.0085	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00334	0.00806	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—CRP—Crohn's disease	0.00326	0.00786	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL1B—Crohn's disease	0.00314	0.00758	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—ALB—Crohn's disease	0.00314	0.00758	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.00299	0.00722	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IFNG—Crohn's disease	0.00287	0.00692	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR9—Crohn's disease	0.00274	0.0066	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00261	0.00629	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL1B—Crohn's disease	0.00256	0.00617	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—GPR65—Crohn's disease	0.00254	0.00614	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—ALB—Crohn's disease	0.0025	0.00602	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00238	0.00574	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.00236	0.00569	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00233	0.00563	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—Crohn's disease	0.00232	0.00559	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.00228	0.0055	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—Crohn's disease	0.00228	0.0055	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IFNG—Crohn's disease	0.00228	0.00549	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—MLN—Crohn's disease	0.00223	0.00538	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—Crohn's disease	0.00218	0.00527	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ACKR2—Crohn's disease	0.00214	0.00516	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0021	0.00506	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—Crohn's disease	0.00203	0.0049	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—F5—Crohn's disease	0.00203	0.00489	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MLN—Crohn's disease	0.00203	0.00489	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—Crohn's disease	0.00186	0.00448	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL6—Crohn's disease	0.00184	0.00444	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR6—Crohn's disease	0.00181	0.00437	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	0.00165	0.00399	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTGER4—Crohn's disease	0.0016	0.00385	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR9—Crohn's disease	0.00155	0.00373	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.00152	0.00367	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL6—Crohn's disease	0.0015	0.00361	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—Crohn's disease	0.00147	0.00356	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GPR65—Crohn's disease	0.00144	0.00347	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR9—Crohn's disease	0.0014	0.00339	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GPR65—Crohn's disease	0.00131	0.00315	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ACKR2—Crohn's disease	0.00126	0.00305	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ITGA4—Crohn's disease	0.00125	0.00301	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL3—Crohn's disease	0.00122	0.00293	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MLN—Crohn's disease	0.0012	0.00289	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.00119	0.00288	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00119	0.00287	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—Crohn's disease	0.00119	0.00287	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RASGRP1—Crohn's disease	0.00118	0.00284	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00114	0.00276	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00114	0.00274	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.00111	0.00269	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.00111	0.00268	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TAGAP—Crohn's disease	0.00109	0.00264	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR6—Crohn's disease	0.00102	0.00247	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RSPO3—Crohn's disease	0.000957	0.00231	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000955	0.0023	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR6—Crohn's disease	0.00093	0.00225	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SEL1L—Crohn's disease	0.000907	0.00219	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000902	0.00218	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2RA—Crohn's disease	0.000852	0.00206	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR9—Crohn's disease	0.00083	0.002	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTGER4—Crohn's disease	0.000819	0.00198	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000812	0.00196	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GPR65—Crohn's disease	0.000771	0.00186	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL3—Crohn's disease	0.000768	0.00185	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000767	0.00185	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000743	0.00179	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL3—Crohn's disease	0.000698	0.00168	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000675	0.00163	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000633	0.00153	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—Crohn's disease	0.000616	0.00149	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000592	0.00143	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—Crohn's disease	0.000584	0.00141	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000582	0.0014	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—JAK2—Crohn's disease	0.000572	0.00138	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR6—Crohn's disease	0.00055	0.00133	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000538	0.0013	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RBX1—Crohn's disease	0.000497	0.0012	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2RA—Crohn's disease	0.000489	0.00118	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTGER4—Crohn's disease	0.000484	0.00117	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—UBE2D1—Crohn's disease	0.000436	0.00105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	0.000425	0.00103	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RIPK2—Crohn's disease	0.000423	0.00102	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL3—Crohn's disease	0.000412	0.000995	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—Crohn's disease	0.000411	0.000992	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RASGRP1—Crohn's disease	0.000399	0.000962	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—JAK2—Crohn's disease	0.000362	0.000873	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTMR3—Crohn's disease	0.000362	0.000872	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SOCS1—Crohn's disease	0.000361	0.000871	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TYK2—Crohn's disease	0.000344	0.000831	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—Crohn's disease	0.00033	0.000797	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—JAK2—Crohn's disease	0.000329	0.000793	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SMAD3—Crohn's disease	0.000312	0.000752	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—Crohn's disease	0.0003	0.000723	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2RA—Crohn's disease	0.000289	0.000697	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FADS1—Crohn's disease	0.000282	0.00068	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX4—Crohn's disease	0.000264	0.000636	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCKR—Crohn's disease	0.000255	0.000615	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TYK2—Crohn's disease	0.000203	0.000491	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JAK2—Crohn's disease	0.000194	0.000468	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000182	0.000439	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—Crohn's disease	0.000177	0.000427	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—Crohn's disease	0.000168	0.000406	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000159	0.000384	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—Crohn's disease	0.000142	0.000344	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—Crohn's disease	9.95e-05	0.00024	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—Crohn's disease	8.11e-05	0.000196	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—Crohn's disease	7.09e-05	0.000171	CbGpPWpGaD
